Unió Europea -
letó -
EMA (European Medicines Agency)
opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanoma - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.
Unió Europea -
letó -
EMA (European Medicines Agency)
sotyktu
bristol-myers squibb pharma eeig - deucravacitinib - psoriāze - imūnsupresanti - treatment of moderate-to-severe plaque psoriasis in adults.
Letònia -
letó -
Pārtikas un veterinārais dienests, Zemkopības ministrija
otoxolan
krka, d.d., novo mesto, slovēnija - marbofloxacin, clotrimasolum, deksametazona acetātu - ausu pilieni, suspensija - suņi
Letònia -
letó -
Zāļu valsts aģentūra
pediaven start-up potassium free šķīdums infūzijām
fresenius kabi polska sp.z o.o., poland - alaninum, argininum, acidum asparticum, acetylcysteinum, acidum glutamicum, glycinum, histidinum, isoleucinum, leucinum, lysini monohydricum, methioninum, phenylalaninum, prolinum, serinum, taurinum, threoninum, tryptophanum, tyrosinum, valinum, glucosum monohydricum, calcii gluconas monohydricus, magnesii lactas dihydricus, zinci acetas dihydricus, cupri sulfas pentahydricus, natrii fluoridum, selenii dioxidum, mangani chloridum tetrahydricum, kalii iodidum, chromii chloridum hexahydricum - Šķīdums infūzijām